CONNECT WITH US
HealthTech

HealthTech

Why humans get the worst of Ebola virus

Medical Xpress logo

Published on

Add as a preferred source on Google
Why humans get the worst of Ebola virus

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Illnesses from Ebola virus and its relatives have about a 50% fatality rate in humans. The current outbreak in the Democratic Republic of Congo has already caused over 10,500 confirmed cases and over 5,130 deaths, according to the U.S. Centers for Disease Control and Prevention.

Ebola virus is a devastating pathogen. Like humans, bats can get infected with Ebola virus. So why don't bats get sick?

"Another puzzle," says lead author Erica Ollmann Saphire, Ph.D., MBA, LJI professor, president and CEO, "is why humans do get so sick. And why the worst cases can have the strongest inflammatory responses. These are strong immune responses, but they're not working well."

In a new Cell study, La Jolla Institute for Immunology (LJI) researchers, working in collaboration with Princeton University professors Aartjan te Velthuis, Ph.D., and Clifford Brangwynne, Ph.D., and UC San Diego professor Gene Yeo, Ph.D., MBA, share a key reason why humans are especially vulnerable to severe Ebola disease.

It may come down to viral "nests." Ebola virus builds protected, bubble-like "nests" inside host cells, technically termed membraneless condensates. The virus harbors its own viral mRNA inside these compartments.

What the researchers found, using a technique called spatial transcriptomics, is that Ebola virus also traps human cellular mRNA molecules inside these nests. When Ebola virus traps certain human mRNAs, the human immune system loses its ability to control dangerous inflammation.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.